About
NextGen Jane develops a molecular diagnostics platform using menstrual blood collected via a patented tampon kit to provide early insights into gynecological health conditions such as endometriosis, adenomyosis, and fibroids.
Explore NextGen Jane's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.